The largest database of trusted experimental protocols

Tlrl pm2s 1

Manufactured by InvivoGen
Sourced in United States

Tlrl-pm2s-1 is a lab equipment product offered by InvivoGen. It serves as a tool for research purposes. Further details about its core function and intended use are not available.

Automatically generated - may contain errors

2 protocols using tlrl pm2s 1

1

Screening Compounds for TLR Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK-Blue hTLR cells lines were seeded in 384-well plate (4 × 104 cells per well) with 20 μL DMEM medium (containing 10% heat-inactivated FBS), and cultured with 20 μL of DMEM medium containing indicated concentrations compounds with or without TLR-specific agonists at 37 °C in a 5% CO2 humidified incubator for 24 h. After incubation, another 40 μL of Quanti-Blue solution (req-qb12, Invivogen) was added and incubated for 30 min. Absorbance was measured at 620 nm using a microplate reader. The IC50 of compound was calculated and processed using Origin 9.0 software. TLR-specific agonists to selectively activate respective TLRs: Poly I:C, lipopolysaccharide (100 ng/mL, tlrl-b5lps, Invivogen), Pam3CSK4 (200 ng/mL, tlrl-pms, Invivogen), Pam2CSK4 (200 ng/mL, tlrl-pm2s-1Invivogen) and R848 (5 μg/mL, tlrl-r848, Invivogen) were used. Value of IC50 were calculated and fitted using Origin 9.0 software.
+ Open protocol
+ Expand
2

TLR Agonists and Antagonist Effects on OECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
OECs were stimulated in a CnT-07 serum-free media with 0.1% penicillin-streptomycin for 24 or 48 h with:

Pam2CSK4, a synthetic TLR2 agonist (tlrl-pm2s-1, InvivoGen, USA) at 0 to 5000 pg/ml,

ultrapure LPS from P. gingivalis (LPS-Pg UP), a TLR4 agonist (tlrl-ppglps, InvivoGen, USA) at 0 to 5000 ng/ml,

standard LPS from P. gingivalis LPS (LPS-Pg STD), TLR2 and TLR4 agonists (tlrl-pglps, InvivoGen, USA) at 0 to 5000 ng/ml,

ultrapure LPS from Rhodobacter sphaeroides (LPS-RS), a strong TLR4 antagonist (tlrl-prslps, InvivoGen, USA) at 0 to 10,000 ng/ml with 30 min pretreatment before TLR stimulation,

Primary OECs were stimulated with 100 ng/mL of recombinant human IL-36γ (6835-IL, R&D, USA) in a CnT-07 serum-free media with 0.1% penicillin-streptomycin for 24 h.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!